Cargando…

Is Vitamin E or Ursodeoxycholic Acid a Valid Treatment Option for Nonalcoholic Fatty Liver Disease in 2016?

Detalles Bibliográficos
Autores principales:	Beaton, Melanie D., Al-Judaibi, Bandar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898083/ https://www.ncbi.nlm.nih.gov/pubmed/27184632 http://dx.doi.org/10.4103/1319-3767.182462

Ejemplares similares

Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
por: Nadinskaia, Maria, et al.
Publicado: (2021)

Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease
por: Nakajima, Kei
Publicado: (2012)

Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice
por: Kim, Ja Kyung, et al.
Publicado: (2014)

Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?
por: Hadi, Hamza El, et al.
Publicado: (2018)

Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2021)

Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid
por: Thérien, Ariane, et al.
Publicado: (2021)

Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
por: Seo, Sang Hyun, et al.
Publicado: (2022)

Vitamin C and Vitamin E in Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in Choline Deficient Diet Fed Rats
por: Oliveira, Claudia PMS, et al.
Publicado: (2003)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Does Vitamin E Improve the Outcomes of Pediatric Nonalcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis
por: Sarkhy, Ahmed A., et al.
Publicado: (2014)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
por: Tanase, Daniela Maria, et al.
Publicado: (2020)

Position statement on the diagnosis and management of non-alcoholic fatty liver disease
por: Alswat, Khalid A., et al.
Publicado: (2019)

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
por: Huang, Xiaolin, et al.
Publicado: (2015)

Ribavirin-free Treatment May Soon be a Reality
por: Al-Judaibi, Bandar
Publicado: (2015)

The New Era of Hepatitis C Virus Therapy
por: Al-Judaibi, Bandar
Publicado: (2015)

Building a Hepatitis C Virus Treatment Strategy to Achieve the 2030 Vision for Saudi Arabia
por: Al-Judaibi, Bandar
Publicado: (2017)

Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006–2016
por: Paik, James M, et al.
Publicado: (2020)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents
por: Ued, Fábio da Veiga, et al.
Publicado: (2013)

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
por: Chung, Goh Eun, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

Gastrointestinal and liver manifestations of COVID-19
por: Cheong, Janice, et al.
Publicado: (2020)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study
por: Kim, Gi Hyun, et al.
Publicado: (2015)

Combination treatment with n-3 polyunsaturated fatty acids and ursodeoxycholic acid dissolves cholesterol gallstones in mice
por: Jang, Sung Ill, et al.
Publicado: (2019)

Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity
por: Zhang, Yunjing, et al.
Publicado: (2019)

The Effect of Bariatric Surgeries on Nonalcoholic Fatty Liver Disease
por: Hassanian, Mazen, et al.
Publicado: (2014)

Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity
por: Buryova, Halka, et al.
Publicado: (2013)

Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review
por: Reardon, Jillian, et al.
Publicado: (2016)

Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid
por: Tamai, Hideyuki, et al.
Publicado: (2023)

Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease
por: Li, Yanyan, et al.
Publicado: (2023)

Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver
por: Foroughi, Mahdi, et al.
Publicado: (2014)

Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis
por: Wang, Ningjian, et al.
Publicado: (2018)

Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?
por: Berasain, Carmen, et al.
Publicado: (2020)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Gender Differences in Nonalcoholic Fatty Liver Disease
por: Nagral, Aabha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ehbnf6qoj59eljvlrugrppsa30